Effects of SGLT2 inhibitors in diabetic patients receiving doxorubicin-based chemotherapy for breast cancer

被引：0
|
作者：
Abdelnabi, M. [1 ]
Hassanein, Z. [2 ]
Benjanuwattra, J. [1 ]
Saleh, Y. [3 ]
Almaghraby, A. [4 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Alexandria Univ, Fac Med, Clin Oncol & Nucl Med Dept, Alexandria, Egypt
[3] Houston Methodist DeBakey Cardiol Associates, Houston, TX USA
[4] Alexandria Univ, Fac Med, Cardiol Dept, Alexandria, Egypt
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [1] Evaluation of Cardiac Comorbidities in Patients with Metastatic Breast Cancer Receiving Doxorubicin-Based and Non-Doxorubicin-Based Chemotherapy
    Lafeuille, M.-H.
    McKenzie, R. S.
    Yameogo, N.-D.
    Senbetta, M.
    Vekeman, F.
    Piech, C. T.
    Lefebvre, P.
    CANCER RESEARCH, 2009, 69 (24) : 618S - 618S
  • [2] Implications of plasma deoxyribonucleic acid topoisomerase 2 beta level in breast cancer patients receiving doxorubicin-based chemotherapy
    Win, T.
    Naing, T. T.
    Win, T. T.
    Aung, K. K.
    Htun, Y. Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] Microparticles and cardiotoxicity secondary to doxorubicin-based chemotherapy in breast cancer patients
    Pestana, Rodrigo M. C.
    Teixeira-Carvalho, Andra
    dos Santos, Luara I.
    de Oliveira, Angelica N.
    Soares, Cintia E.
    Sabino, Adriano de P.
    Simoes, Ricardo
    Gomes, Karina B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 395
  • [4] New Cardiovascular Biomarkers in Breast Cancer Patients Undergoing Doxorubicin-Based Chemotherapy
    Pestana, Rodrigo Mendonca Cardoso
    Silvino, Junea Paolucci Paiva
    de Oliveira, Angelica Navarro
    Soares, Cintia Esteves
    de Paula Sabino, Adriano
    Simoes, Ricardo
    Gomes, Karina Braga
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2023, 120 (12)
  • [5] Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer - Tolerance and outcome
    Ibrahim, NK
    Frye, DK
    Buzdar, AU
    Walters, RS
    Hortobagyi, GN
    ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (08) : 882 - 888
  • [6] SGLT2 Inhibitors and the Diabetic Kidney
    Fioretto, Paola
    Zambon, Alberto
    Rossato, Marco
    Busetto, Luca
    Vettor, Roberto
    DIABETES CARE, 2016, 39 : S165 - S171
  • [7] Diabetic ketoacidosis with SGLT2 inhibitors
    Musso, Giovanni
    Saba, Francesca
    Cassader, Maurizio
    Gambino, Roberto
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [8] Effects of SGLT2 Inhibitors on Cardiac Mechanics in Hispanic and Black Diabetic Patients
    Moras, Errol
    Shrivastav, Rishi
    Gandhi, Kruti D.
    Bandyopadhyay, Dhrubajyoti
    Isath, Ameesh
    Goel, Akshay
    Bella, Jonathan N.
    Contreras, Johanna
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [9] ANTIATHEROSCLEROTIC EFFECTS OF SGLT2 INHIBITORS IN TYPE 2 DIABETIC PATIENTS WITH OBESITY AND HYPERTENSION
    Yamagishi, T.
    ATHEROSCLEROSIS, 2018, 275 : E62 - E62
  • [10] SGLT2 inhibitors in diabetic nephropathy Mechanisms and clinical effects
    Dumann, E.
    Haller, H.
    Menne, J.
    NEPHROLOGE, 2020, 15 (03): : 153 - 162
12345